Literature DB >> 12758206

Involving private health care providers in delivery of TB care: global strategy.

Mukund Uplekar1.   

Abstract

Most poor countries have a large and growing private medical sector. Evidence suggests that a large proportion of tuberculosis patients in many high TB- burden countries first approach a private health care provider. Further, private providers manage a significant proportion of tuberculosis cases. Surprisingly though, there is virtually no published evidence on linking private providers to tuberculosis programmes. As a part of global efforts to control tuberculosis through effective DOTS implementation, the World Health Organization has recently begun addressing the issue of private providers in TB control through an evolving global strategy. As a first step, a global assessment of private providers' participation in tuberculosis programmes was undertaken. The findings of the assessment were discussed and debated in a consultation involving private practitioners, TB programme managers and policy makers. Their recommendations have contributed to the evolving global strategy called Public-Private Mix for DOTS implementation (PPM DOTS). This paper presents the guiding principles of PPM DOTS and major elements of the global strategy. These include: informed advocacy; setting-up "learning projects"; scaling-up successful projects and formulation of regional, national and local strategies; developing practical tools to facilitate PPM DOTS and pursuing an operational research agenda to help better design and shape PPM DOTS strategies. Encouraging results from some ongoing project sites are discussed. The paper concludes that concerted global efforts and local input are required for a sustained period to help achieve productive engagement of private practitioners in DOTS implementation. Such efforts have to be targeted as much towards national tuberculosis programmes as towards private providers and their associations. Continued apathy in this area could not only potentially delay achieving global targets for TB control but also undo, in the long run, the hard-earned achievements of National TB Programmes.

Entities:  

Mesh:

Year:  2003        PMID: 12758206     DOI: 10.1016/s1472-9792(02)00073-2

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  31 in total

1.  The perspective of private practitioners regarding tuberculosis case detection and treatment delay in Amhara Region, Ethiopia: a cross-sectional study.

Authors:  Solomon A Yimer; Carol-Holm Hansen; Gunnar A Bjune
Journal:  BMC Res Notes       Date:  2011-08-11

Review 2.  Multidrug-resistant to extensively drug resistant tuberculosis: what is next?

Authors:  Amita Jain; Pratima Dixit
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

3.  Market size and sales pattern of tuberculosis drugs in the Philippines.

Authors:  T Islam; C van Weezenbeek; R Vianzon; A M C G Garfin; T Hiatt; W J Lew; K Tisocki
Journal:  Public Health Action       Date:  2013-12-21

4.  Barriers and Motivators of private hospitals' engagement in Tuberculosis care in Uganda.

Authors:  Wilson Tumuhimbise; Angella Musiimenta
Journal:  Glob Implement Res Appl       Date:  2021-11-08

5.  Immigrants and health system challenges to TB control in Oman.

Authors:  Abdullah Al-Maniri; Grethe Fochsen; Omar Al-Rawas; Ayesha De Costa
Journal:  BMC Health Serv Res       Date:  2010-07-16       Impact factor: 2.655

6.  Factors Related to Non-Referral of Patients with Presumptive Pulmonary TB to Designated Microscopy Centers (DMCs) by Registered Private Practitioners in Urban Areas of Punjab, India.

Authors:  Sarit Sharma; Shruti Sharma; Jagdeep Whig; Mahesh Satija; Anurag Chaudhary
Journal:  J Clin Diagn Res       Date:  2015-11-01

7.  Investigation of presumptive tuberculosis cases by private health providers: lessons learnt from a survey in Pakistan.

Authors:  R Fatima; E Qadeer; D A Enarson; S G Hinderaker; R Harris; A Yaqoob; A Bassili
Journal:  Public Health Action       Date:  2014-06-21

8.  Public and/or private health care: tuberculosis patients' perspectives in Myanmar.

Authors:  Saw Saw; Lenore Manderson; Mridula Bandyopadhyay; Than Tun Sein; Myo Myo Mon; Win Maung
Journal:  Health Res Policy Syst       Date:  2009-07-28

9.  Perceptions of the Private Sector for Creating Effective Public-Private Partnerships against Tuberculosis in Metro Manila, Philippines.

Authors:  James Sherpa; Rajendra-Prasad Yadav
Journal:  Am J Trop Med Hyg       Date:  2019-09       Impact factor: 2.345

10.  What Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?

Authors:  Kabir Sheikh; Mukund Uplekar
Journal:  Int J Health Policy Manag       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.